Biolabs International’s New App Cuts Clinic Visits, Expands Testing Access

Biolabs’ CONNECTED DIAGNOSTICS App and decentralized clinical trial platform integrates rapid diagnostic testing, artificial intelligence, and telehealth, all accessible from a smartphone

SAN DIEGO, Aug. 19, 2025 /PRNewswire/ — Biolabs International LLC, a healthcare innovation company based in San Diego, California, is transforming how diagnostics are delivered and accessed , both in the home and in clinical research. Through the rollout of its CONNECTED DIAGNOSTICS App and decentralized clinical trial platform, Biolabs is eliminating unnecessary doctor visits, reducing barriers to care, setting new standards for accessible, AI-powered healthcare and facilitating the FDA registration and approval process for future diagnostic tools.

At the center of this advancement is the integration of rapid diagnostic testing, artificial intelligence, and telehealth, all accessible from a smartphone or iPad. Consumers can now self-administer a SpeedySwab™ test at home, scan a QR code on the SpeedySwab™ box and can be downloaded on both Apple and Google store, receive AI-interpreted results in minutes, and connect with healthcare professionals on-demand, all without leaving their home.

Click this link to the SpeedySwab™ App.

Less Waiting, More Empowerment Biolabs’ approach significantly reduces the need for in-person clinic visits. Instead of waiting days for appointments or exposing others in crowded waiting rooms, users can now test and receive care at home. The app includes step-by-step guidance, AI-driven result analysis, and the option to launch a telehealth consultation immediately if needed.

This real-time, remote care model not only alleviates pressure on critical healthcare infrastructure but also enhances accessibility for individuals in rural, underserved, or high-risk environments. By reducing overall healthcare costs and lessening the strain on the system during peak flu seasons or pandemics, Biolabs is facilitating the secure and reliable delivery of diagnostic results, whether administered at home, in-clinic, or via kiosk directly to EHRs, HIEs, and retail health ecosystems through its SAFE platform.

AI-Driven Accuracy and Integration The CONNECTED DIAGNOSTICS App, developed in collaboration with SafeHealth Systems and the Mayo Clinic is not just a digital interface, it’s an AI-powered diagnostic assistant. The platform uses proprietary algorithms to interpret lateral flow test results, minimizing human error and improving reliability for users.

All data is encrypted and HIPAA-compliant, with secure sharing options for healthcare providers, employers, or public health agencies. The app is also integrated with telehealth capabilities, enabling users to receive real-time medical advice and prescriptions based on their test results. Biolabs International is eliminating unnecessary doctor visits, reducing barriers to care, and setting new standards for accessible, AI-powered healthcare.